BOVIE MEDICAL CORPORATION (NYSEMKT:BVX) Files An 8-K Results of Operations and Financial Condition
Item 2.02 – Results of Operations and Financial Condition
issued a press release reporting on its results of operations for
the fourth quarter and full year ended December 31, 2016. A copy
of that press release is attached hereto as Exhibit 99.1 and
incorporated by reference herein. Such information, including the
Exhibit 99.1 attached hereto, shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933, as amended, except as
shall be expressly set forth by specific reference in such
filing.
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press release dated March 9, 2017
|
About BOVIE MEDICAL CORPORATION (NYSEMKT:BVX)
Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It operates through three segments: Core, OEM and J-Plasma. It is engaged in developing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor’s offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium-based plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit, a handpiece and a supply of helium gas. Its products are marketed through brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. It offers its products in electrosurgery, cauteries and other products categories. BOVIE MEDICAL CORPORATION (NYSEMKT:BVX) Recent Trading Information
BOVIE MEDICAL CORPORATION (NYSEMKT:BVX) closed its last trading session up +0.02 at 3.25 with 116,799 shares trading hands.
